Novo A/S as of Dec. 31, 2014
Portfolio Holdings for Novo A/S
Novo A/S holds 15 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 25.5 | $316M | 3.0M | 106.00 | |
| Ophthotech | 21.4 | $265M | 5.9M | 44.87 | |
| Inogen (INGN) | 9.0 | $111M | 3.5M | 31.37 | |
| Vanguard Intl Equity Index F Ftse Europe Etf (VGK) | 8.9 | $110M | 2.1M | 52.41 | |
| Alder Biopharmaceuticals | 7.5 | $93M | 3.2M | 29.09 | |
| Nevro (NVRO) | 6.9 | $85M | 2.2M | 38.67 | |
| Otonomy | 5.9 | $73M | 2.2M | 33.33 | |
| Tetraphase Pharmaceuticals | 4.7 | $59M | 1.5M | 39.71 | |
| Flexion Therapeutics | 3.7 | $46M | 2.3M | 20.19 | |
| Wright Medical Group Contingent Value Rights (Principal) | 1.8 | $23M | 4.7M | 4.78 | |
| Akebia Therapeutics (AKBA) | 1.4 | $18M | 1.5M | 11.64 | |
| Tokai Pharmaceuticals | 1.4 | $17M | 1.2M | 14.74 | |
| Aerie Pharmaceuticals | 1.0 | $12M | 420k | 29.19 | |
| Intersect Ent | 0.5 | $6.5M | 350k | 18.55 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $2.5M | 128k | 19.75 |
